Yann Mazabraud's Net Worth

$2.6 Million

Estimate Recalculated Nov 11, 2024 01:40PM EST

Who is Yann Mazabraud

Yann Mazabraud has an estimated net worth of $2.6 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., and Trevi Therapeutics, Inc..

SEC CIK

Yann Mazabraud's CIK is 0001774702

Past Insider Trading and Trends

2024 was Yann Mazabraud's most active year for acquiring shares with 7 total transactions. Yann Mazabraud's most active month to acquire stocks was the month of January. 2024 was Yann Mazabraud's most active year for disposing of shares, totalling 9 transactions. Yann Mazabraud's most active month to dispose stocks was the month of January. 2020 saw Yann Mazabraud paying a total of $0.00 for 170,000 shares, this is the most they've acquired in one year. In 2024 Yann Mazabraud cashed out on 53,675 shares for a total of $757,116.60, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC.

EVP, Head International
Updated Apr 16, 2024
Form 4
-11.24%
-10.75K
Apr 16, 2024
84.90K
Options
Apr 14 - Apr 15
Form 4
-39.51%
-16.00K
$39.22
-$627.52K
Mar 19, 2024
24.50K
Sale
Mar 19
Form 4
1,819.87%
122.75K
Feb 21, 2024
129.50K
Grant
Feb 16
Form 4
-14.02%
-2.55K
$50.80
-$129.60K
Feb 13, 2024
15.65K
Sale
Feb 09 - Feb 13
Form 4
Apr 18, 2023
41.50K
Acq/Dis
Apr 14
Form 4
-23.52%
-1.18K
$27.03
-$31.81K
Feb 16, 2023
3.83K
Sale
ScheduledFeb 14
Form 4
Feb 14, 2023
9.07K
Options
Feb 11
Form 4/A
-34.46%
-1.56K
$27.51
-$43.00K
Feb 14, 2023
2.97K
Sale
ScheduledFeb 09
Form 4
-10.43%
-1.55K
$27.66
-$42.82K
Feb 13, 2023
13.30K
Sale
ScheduledFeb 09
Form 4
41.50K
Feb 03, 2023
41.50K
Grant
Feb 01
Form 4
-11.50%
-934.00
$6.10
-$5.70K
Feb 15, 2022
7.19K
Sale
ScheduledFeb 11 - Feb 15
Form 4
96.25K
Feb 11, 2022
96.25K
Grant
Feb 09
Form 4
56.88K
Feb 16, 2021
56.88K
Grant
Feb 11
Form 4
100.00K
Oct 06, 2020
100.00K
Grant
Oct 05
Form 3
Oct 06, 2020
Showing 15 results

Trevi Therapeutics, Inc.

See Remarks
Updated Feb 18, 2020
Form 4
70.00K
Feb 18, 2020
70.00K
Grant
Feb 13
Form 4
50.00K
Jun 05, 2019
50.00K
Grant
Jun 03
Form 3
May 07, 2019
Showing 3 results